Latest Distribution Agreements News

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

Universal Biosensors reported a 28% increase in customer receipts to $1.6 million for Q1 2025, alongside improved cash flow and plans for a new product launch later this year.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

Osteopore Limited reported a robust 26% quarter-on-quarter revenue increase in Q1 CY25, bolstered by a key Singapore subsidy listing and a strategic pivot away from its dental project to sharpen commercial focus.

Sprintex Limited has advanced its commercial and technological milestones with major European and Indian orders, breakthrough energy efficiency validation, and a successful A$3.25 million equity raise, positioning the company for accelerated growth.

Aumake Limited reports a robust 160% year-on-year surge in quarterly cash receipts to A$12.7 million, driven by new strategic partnerships and operational efficiencies. The company also implements executive salary cuts to sharpen its path toward cash flow positivity.

HUB24 has delivered a robust half-year performance for 1HFY25, marked by significant revenue growth, record net inflows, and expanding adviser engagement, reinforcing its leadership in Australia’s wealth management technology sector.

HUB24 has reported a robust first half FY25 with a 41% jump in underlying EBITDA and upgraded its FY26 platform funds under administration target, underscoring its accelerating market momentum.

RLF AgTech has completed a $2.4 million capital raise through an Entitlement Issue and Shortfall Placement, positioning the company for growth in Australia’s agricultural sector.

Osteopore Limited has announced a $20 million convertible notes offering aimed at bolstering its capital for ongoing operations and future projects. The highly speculative offer targets sophisticated investors and underscores the company’s strategic funding approach amid competitive medical device markets.

De.mem Limited has secured a strategic distribution agreement with Singapore’s Firmbase Pte Ltd to penetrate key Asian markets, including China, Indonesia, and Japan, marking its first commercial sale in China’s burgeoning home water filtration sector.

Inventis Limited updates its operational review with corrected financials, securing major orders and pursuing significant capital raises to fuel international expansion.